US equities
|
NVDA
$237.83
▲+1.66%
SPCX
$167.84
▲+5.59%
MU
$1,063.31
▼-1.08%
TSLA
$379.00
▲+2.27%
MSFT
$525.00
▲+1.44%
SNDK
$1,711.17
▼-0.51%
INTC
$116.98
▼-1.97%
META
$742.24
▲+1.94%
NVDA
$237.83
▲+1.66%
SPCX
$167.84
▲+5.59%
MU
$1,063.31
▼-1.08%
TSLA
$379.00
▲+2.27%
MSFT
$525.00
▲+1.44%
SNDK
$1,711.17
▼-0.51%
INTC
$116.98
▼-1.97%
META
$742.24
▲+1.94%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Aclaris Therapeutics, Inc. - Common Stock
(NQ:
ACRS
)
4.205
-0.185 (-4.21%)
Delayed Quote
Updated: 2:11 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aclaris Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
June 08, 2021
Gainers Aethlon Medical (NASDAQ:AEMD) sto...
Via
Benzinga
Mid-Afternoon Market Update: Crude Oil Rises Over 1%; Aclaris Therapeutics Shares Plunge
↗
June 08, 2021
Toward the end of trading Tuesday, the Dow traded up 0.01% to 34,634.62 while the NASDAQ rose 0.29% to 13,921.88. The S&P also rose, gaining 0.04% to 4,228.15. The U.S. has...
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
June 08, 2021
Gainers Cyclerion Therapeutics (NASDAQ:CYCN) stock increased by 37.46% to $4.33 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 9...
Via
Benzinga
Mid-Day Market Update: Coupa Software Drops After Q1 Results; NextDecade Shares Jump
↗
June 08, 2021
Midway through trading Tuesday, the Dow traded down 0.09% to 34,598.11 while the NASDAQ rose 0.09% to 13,894.14. The S&P also fell, dropping 0.09% to 4,222.88. The U.S. has...
Via
Benzinga
Topics
Stocks
50 Stocks Moving In Tuesday's Mid-Day Session
↗
June 08, 2021
Gainers Clover Health Investments, Corp. (NASDAQ: CLOV) shares jumped 72.4% to $20.55 amid increased retail investor interest in the stock. NextDecade Corporation (NASDAQ: NEXT...
Via
Benzinga
Aclaris' ATI-1777 Aces Atopic Dermatitis Trial with Minimal Systemic Exposure
↗
June 08, 2021
Aclaris Therapeutics Inc (NASDAQ: ACRS) has announced preliminary topline results from its Phase 2a trial evaluating ATI-1777 for moderate to severe atopic...
Via
Benzinga
These 7 Medical Stocks Are Breaking Down — The Sell Rule You Should Know
↗
May 13, 2021
Former high-flyers Dexcom and Tandem Diabetes are among seven health care stocks breaking down right now, according to MarketSmith.com.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2021
↗
April 21, 2021
Upgrades For Cerecor Inc (NASDAQ:CERC), Maxim Group upgraded the previous rating of Hold to Buy. In the fourth quarter, Cerecor showed an EPS of $0.19, compared to $0.10...
Via
Benzinga
The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs
↗
April 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 8) Aclaris Therapeutics, Inc...
Via
Benzinga
The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data
↗
April 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 7) Aclaris Therapeutics, Inc...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
